According to the source, 21Shares filed an S-1 registration statement with the U.S. SEC to launch an Injective (INJ) ETF, a claim traders should validate by confirming an accepted S-1 entry and any subsequent S-1/A amendments on the SEC EDGAR system (source: SEC EDGAR). For process and timing, monitor the related exchange 19b-4 rule filing and the SEC Division of Corporation Finance comment-letter cycle, which typically precedes any registration becoming effective (source: SEC Division of Trading and Markets; source: SEC Division of Corporation Finance). Near term, actionable catalysts are EDGAR acceptance, exchange listing filings, and shifts in INJ spot and perpetuals liquidity; prioritize official filings over headlines when sizing risk and setting stops (source: SEC filings; source: exchange market data).